E-LIB Suche - Ergebnisse für: Ruilope Urioste, Luis Miguel

Sorted by: Relevance

Sorted by: Year

Comments on the 2016 ESC Guidelines for the Diagnosis and T..:

Sionis, A. ; Sionis Green, Alessandro ; Manito Lorite, Nicolas...
Revista Española de Cardiología (English Edition). 69 (2016) 12 - p. 1119-1125 , 2016

Link: https://doi.org/10.1016/..

Prevalence, awareness, treatment and control of hypertensio..:

de Pablos-Velasco, Pedro ; Martínez-Martín, Francisco Javier ; Pérez, Fátima Rodríguez..
Journal of Hypertension. 20 (2002) 10 - p. 1965-1971 , 2002

Link: https://doi.org/10.1097/..

Finerenone protects against progression of kidney and cardi..:

Sanz-Gómez, Marta ; Manzano Lista, Francisco J ; Vega Martín, Elena...
Biomedicine & Pharmacotherapy. , 2023

Link: http://hdl.handle.net/10..

Finerenone protects against progression of kidney and cardi..:

Sanz-Gómez, Marta ; Manzano Lista, Francisco J ; Vega Martín, Elena...
Biomedicine & Pharmacotherapy. , 2023

Link: http://hdl.handle.net/10..

Finerenone in Predominantly Advanced CKD and Type 2 Diabete..:

Rossing, Peter ; Filippatos, Gerasimos S ; Agarwal, Rajiv L...
Rossing, P., Filippatos, G., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Chan, J. C. N., Kooy, A., McCafferty, K., Schernthaner, G., Wanner, C., Joseph, A., Scheerer, M. F., Scott, C., & Bakris, G. L. (2022). Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy. Kidney International Reports. 7(1), 36-45. https://doi.org/10.1016/j.ekir.2021.10.008. , 2022

Link: http://hdl.handle.net/11..

Hyperkalemia Risk with Finerenone: Results from the FIDELIO..:

Agarwal, Rajiv L ; Joseph, Amer ; Anker, Stefan D...
https://doi.org/10.1681/ASN.2021070942. , 2022

Link: http://hdl.handle.net/11..

Finerenone Reduces Risk of Incident Heart Failure in Patien..:

Filippatos, Gerasimos S ; Anker, Stefan D ; Agarwal, Rajiv L...
Filippatos, G., Anker, S. D., Agarwal, R., Ruilope, L. M., Rossing, P., Bakris, G. L., Tasto, C., Joseph, A., Kolkhof, P., Lage, A., Pitt, B., & FIGARO-DKD Investigators (2022). Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial. Circulation, 145(6), 437–447. https://doi.org/10.1161/CIRCULATIONAHA.121.057983. , 2022

Link: http://hdl.handle.net/11..

Effects of canagliflozin versus finerenone on cardiorenal o..:

Agarwal, Rajiv L ; Anker, Stefan D ; Filippatos, Gerasimos S...
Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, P., Ruilope, L. M., Boletis, J., Toto, R., Umpierrez, G. E., Wanner, C., Wada, T., Scott, C., Joseph, A., Ogbaa, I., Roberts, L., Scheerer, M. F., & Bakris, G. L. (2022). Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 37(7), 1261–1269. https://doi.org/10.1093/ndt/gfab336. , 2022

Link: http://hdl.handle.net/11..

Hypertension mediated kidney and cardiovascular damage and ..:

Márquez, Diego Francisco ; Rodríguez Sánchez, Elena ; Segura, Julián..
Márquez, D. F., Rodríguez-Sánchez, E., Segura de la Morena, J., Ruilope, L. M., & Ruiz-Hurtado, G. (2021). Hypertension mediated kidney and cardiovascular damage and risk stratification: Redefining concepts. Nefrología, 41(4), 446-452. https://doi.org/10.1016/j.nefro.2021.10.003. , 2022

Link: http://hdl.handle.net/11..

Joint association of physical activity and body mass index ..:

Valenzuela Ruiz, Pedro Luis ; Santos Lozano, Alejandro ; Torres Barrán, Alberto...
https://doi.org/10.1093/eurjpc/zwaa151. , 2022

Link: http://hdl.handle.net/11..

Finerenone in Patients With Chronic Kidney Disease and Type..:

Rossing, Peter ; Burgess, Ellen ; Agarwal, Rajiv L...
https://doi.org/10.2337/dc21-1944. , 2022

Link: http://hdl.handle.net/11..

Use of chronic kidney disease blind spot to prevent cardior..:

Ruilope Urioste, Luis Miguel ; Ruiz Hurtado, Gema ; Miranda, Blanca.
https://doi.org/10.1093/eurheartj/ehab456. , 2022

Link: http://hdl.handle.net/11..

Cardiovascular and kidney outcomes with finerenone in patie..:

Agarwal, Rajiv L ; Filippatos, Gerasimos S ; Pitt, Bertram...
Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M., & FIGARO-DKD. (2022). Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. European Heart Journal, 43(6), 474-484. https://doi.org/10.1093/eurheartj/ehab777. , 2022

Link: http://hdl.handle.net/11..

The anti-aging factor Klotho protects against acquired long..:

Navarro García, José Alberto ; Salguero Bodés, Rafael ; González Lafuente, Laura...
Navarro-García, J. A., Salguero-Bodés, R., González-Lafuente, L., Martín-Nunes, L., Rodríguez-Sánchez, E., Bada-Bosch, T., Hernández, E., Mérida-Herrero, E., Praga, M., Solís, J., Arribas, F., BueNo, H., Kuro-O, M., Fernández-Velasco, M., Ruilope, L. M., Delgado, C., & Ruiz-Hurtado, G. (2022). The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23. BMC Medicine, 20(1), 14. https://doi.org/10.1186/s12916-021-02209-9. , 2022

Link: http://hdl.handle.net/11..

Poor self-reported sleep is associated with risk factors fo..:

Valenzuela Ruiz, Pedro Luis ; Santos Lozano, Alejandro ; Torres Barrán, Alberto...
Valenzuela, P. L., Santos‐Lozano, A., Torres‐Barrán, A., Morales, J. S., Castillo‐García, A., Ruilope, L. M., Ríos‐Insua, D., Ordovás, J. M., & Lucía, A. (2022). Poor self‐reported sleep is associated with risk factors for cardiovascular disease: A cross‐sectional analysis in half a million adults. European Journal of Clinical Investigation. 52(5), e13738. https://doi.org/10.1111/eci.13738. , 2022

Link: http://hdl.handle.net/11..

1-15